All In Biotech

Drug Trial Radar · NCT02129751

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 246 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

246

Planned (sponsor's estimate)

Start

Jul 1, 2027

Primary completion

Jul 2030

Study completion Dec 2030

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
May 2, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Single group
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety

Conditions

  • Major Depressive Disorder

Interventions

  • bupropion hydrobromideDrug

    study drug

  • PlaceboDrug

    placebo arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from Baseline to EOT in total CDRS-R (raw) scoreTime frame: Baseline and 2 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.